Page 5 - Alpha Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of

GARCHING, Germany, MUNICH Germany and CHALK RIVER, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL),

Chalk riverGerrit siegersBen orzelekPhilip kompassFred dermarkarJeremy lattaSteffen schusterJoe mcbreartyCorporate communicationsCanadian nuclear laboratoriesAtomic energy of canada limitedTechnologies munichAtomic energyCanada limitedActinium production facilityGood manufacturing process

ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225

New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale quantities of rare medical isotope

Chalk riverJoe mcbreartySteffen schusterFred dermarkarActineer incCanadian nuclear laboratoriesAtomic energy of canada limitedTechnologies munichAtomic energyCanada limitedActinium production facilityGood manufacturing processChalk river laboratoriesTargeted alpha therapyAlpha therapy

Orano Med and Orbit Discovery collaborate on radioligand therapies for cancer

Orano Med and Orbit Discovery collaborate on radioligand therapies for cancer
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Julien dodetOrbit discoveryNeil buttOrano medAlpha therapy

Perspective Therapeutics to Present Clinical and Preclinical Data at the 36th Annual Congress of the European Association of Nuclear Medicine

Perspective Therapeutics to Present Clinical and Preclinical Data at the 36th Annual Congress of the European Association of Nuclear Medicine
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United statesMarkus puhlmannThijs spoorChuck padalaDharmender malikDepartment of energyConsultant nuclear medicinePerspective therapeutics incExchange commissionEuropean association of nuclear medicinePrincipal research scientistPerspective therapeuticsTargeted alpha particleAnnual congressEuropean associationNuclear medicine

Actinium Pharmaceuticals Announces Iomab-B SIERRA Trial Database Lock, Provides Corporate Update Highlighting Key Upcoming Milestones

On track to report topline data from the Pivotal Phase 3 SIERRA trial for Iomab-B in Q4 2022 Overall survival data from the Actimab-A CLAG-M combination trial.

United statesHans vitzthumSandesh sethActinium technology platformLifesci advisorsAlpha therapy programTechnology platformResearch programsDrug administrationAmerican society for transplantationInternational blood marrow transplant researchExchange commissionActinium pharmaceuticals incEuropean medicines agencyPrnewswire actinium pharmaceuticals incPivotal phase